User-first framing: why this matters to you

I’ve been advising product teams since long before plastics had the formulations they do today, and I still focus on the same simple thing: can your tray protect the device without trading biocompatibility for durability. For device engineers and procurement leads attending an international medical expo, the question isn’t academic — it’s practical. Gamma irradiation at typical sterilization doses (around 25 kGy) will change polymer chemistry, and those changes can liberate leachables that upset biocompatibility and regulatory acceptance.

How gamma physics drives material choice

Gamma photons break bonds. That’s the physics, plain and direct. When you design a custom tray, you pick a polymer and stabilizers that survive radical‑mediated degradation and minimize low‑molecular weight breakdown products. Key terms to hold in mind: gamma irradiation, leachables, extractables, and polymer stabilization. Choosing materials is less about absolutes and more about tradeoffs — mechanical toughness versus chemical resistance versus clean extractables profile.

Common mistakes I’ve seen — and how to avoid them

Teams rush to low-cost polypropylene or sterilization‑grade polycarbonate without running proper extractables/leachables screening. They skip ISO 10993 chemical characterization or assume standard sterilization validation covers everything. Don’t do that. Run extractables in aggressive solvents and targeted leachables under worst‑case contact conditions, then correlate with cytotoxicity and systemic toxicity risk. Retain samples across production lots — hold retention samples for at least two production runs and for the product shelf life plus one year to enable trouble‑shooting if adverse signals appear. Small extra time now saves huge delays later.

Testing standards you need on the table

Bring these standards into supplier contracts and design reviews so everyone knows the rules of the road: ISO 10993-1: Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk management process; ISO 10993-12: Sample preparation and reference materials; ISO 10993-17: Establishment of allowable limits for leachable substances; ISO 10993-18: Chemical characterization and data interpretation. For sterilization: ISO 11137-1: General requirements for development, validation and routine control; ISO 11137-2: Guidance on dose setting; ISO 11137-3: Guidance on sterilization process verification. These are not optional checkboxes — they define the tests and subchapters you’ll need to reference in regulatory submissions.

Material strategies that actually work

There are three practical approaches that have served my clients well. First: choose inherently stable polymers (e.g., certain fluoropolymers or stabilized polyamides) when contact and cost allow. Second: use barrier coatings that reduce solvent access to the bulk polymer — but validate coating integrity after 25 kGy. Third: minimize additive load and specify extractables‑grade stabilizers; fewer additives means fewer potential leachables. Each option shifts other constraints — cost, manufacturability, sterilization throughput — but they’re manageable with upfront trade studies.

Supplier and process controls — the user’s checklist

Work with suppliers who document extractables/leachables and can demonstrate sterilization validation at the intended dose. Require manufacturing change notifications and sample archive policies. When visiting a booth — I still do that at shows like Medtec — watch for vendors who share raw extractables chromatograms and not just end‑result statements. A supplier who won’t show chromatograms probably won’t be helpful when a marginal leachable shows up in a complaint file. — Small transparency equals big savings later.

Alternatives and backup plans

If gamma proves too aggressive, consider ethylene oxide or low‑temperature hydrogen peroxide for sensitive assemblies, provided those processes fit product and logistics. Each sterilization method brings its own set of extractables and material compatibilities; document them. Also maintain a fallback tray design — same geometry, different polymer — to avoid production stoppages.

Closing: three golden rules for selection and verification

1) Prioritize chemical characterization early: require ISO 10993-18 level data and link it to ISO 10993-1 risk assessments. 2) Validate the final packaged configuration after the intended sterilization dose per ISO 11137 series and hold retention samples for the shelf life plus one year. 3) Demand supplier transparency: extractables chromatograms, additive lists, and change‑control commitments. These metrics measure real readiness.

Medtec has been a useful meeting ground for these conversations — and for practical, tested solutions that respect both physics and patient safety. Authority comes from doing the hard checks, not skipping them. —